Overview

Flu Vaccines Market Dynamics:

Influenza is a contagious respiratory infection that causes cough, runny nose, severe illness. As per the World Health Organization, 2018, over 4 million people were diagnosed with severe illness whereas over 0.1 million influenza-related deaths were registered. Additionally, as per the report published by Center for Disease Control and Prevention in 2019, over 90 pediatric deaths were registered owing to flu. Furthermore, growing research and development activities along with current clinical trials for developing novel flu vaccines shall bolster the flu vaccines market growth.
Moreover, rise in the number of healthcare centers in both developed and developing nations has boosted the proliferation of the market. Additionally, many key players are heavily investing in research and development activities for increasing their manufacturing capabilities and the product spectrum. These vendors are establishing new facilities for enhancing their production capabilities. The demand for flu vaccines has skyrocketed due to the current COVID-19 pandemic and many companies are initiating in producing vaccines for this virus. For example, Bharat Biotech has declared to collaborate with FluGen, a US-based biotech company and the University of Wisconsin Madison for experimenting with flu vaccines that have the potential of fighting off the SARS COV-2 virus. Many players have also reached the levels of advance clinical trials and government bodies are providing financial as well as infrastructural support to these companies.

Flu Vaccines Market Segmentation:

By Product Type
• Trivalent Flu Vaccines
• Quadrivalent Flu Vaccines

By Dosage Form
• Intramuscular Injection
• Nasal Sprays
• Intradermal Shot

By Distribution Channel
• Hospitals
• Community Clinics
• Public Health Agencies
• Workplace Purchasing
• Retail Pharmacy
• Mail Order Pharmacy

By Region
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

The market is categorized into product type, dosage form, distribution channel and region. The product type segment is fragmented into trivalent vaccines and quadrivalent vaccines. The dosage form segment is classified into intradermal shots, intramuscular injection and nasal shots. The distribution channel segment is diversified into hospitals, community clinics, public health agencies, workplace purchasing, retail pharmacy and mail order pharmacy. The hospital segment is anticipated to hold the largest flu vaccines market share owing to a rise in the number of multispecialty hospitals and advancements in the hospital infrastructure.

Regional Analysis:
The North America region is expected to dominate the market and this can be credited to the rising awareness regarding the spread and prevention of flu, growing investments in the research and development of flu vaccines, favorable reimbursement policies and a strong presence of key market players in the region. The Europe region has experienced the growing prevalence of flu in the region which has boosted the market growth in the region.

Competitive Landscape:
The major market players associated are Sanofi Pasteur Inc. (Sanofi S/A), AstraZeneca, Abbott, GlaxoSmithKline Plc., Serum Institute of India Pvt. Ltd., CSL Ltd. (Seqirus), Zydus Cadila, Bharat Biotech, Panacea Biotech, Mylan, Sinovac Biotech,Mitsubishi Tanabe Pharma.

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key market trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the global flu vaccines market by product type, by dosage form, by distribution channel and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
• To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com